Our Strategy

Our Purpose

To give the best possible care to animals 

Our Vision

To be the veterinary company people most want to work for

Supported By Four Strategic Pillars

We recommend and provide the best care every time
We are a great place to work and have a career
We provide great facilities and equipment
We take our responsibilities seriously

Underpinned by our ESG Strategy - "Care At Our Heart"

Find out more about our ESG Strategy

Our 2023 Operational highlights

  • We have continued to increase investment in our facilities and equipment, investing £45.7m in 2023, an increase of £21.2m vs 2022, including completing 21 refurbishment and relocation projects in the year.
  • We have acquired 11 practices (16 practice sites).
  • We have increased the average number of vets we employ by 6.5%.
  • We introduced sustainability targets across our Sustainability working groups, read more on pages 32 to 46 of our 2023 Annual Report.
  • In July 2023, we entered the Australian veterinary market with the acquisition of five practices (five practice sites), with more now completed.

Our 2023 Financial highlights1

  • Revenue increased by 9.8%, to £608.3m from £554.2m, with strong Group like-for-like growth of 7.3% (2022: 8.0%) driven by a continued focus on providing high-quality clinical care.
  • The Group delivered adjusted EBITDA growth of 13.0%, to £121.4m from £107.4m, as a result of the above revenue growth, the continued investment in our colleagues and the recognition of research and development expenditure tax credit.
  • Profit before tax increased by 49.7% to £53.9m from £36.0m.
  • Leverage increased to 0.73x from 0.40x as a result of increased investment in existing practices and acquisitions, partly offset by increased EBITDA.
  • Cash generated from operations increased by 15.9%, to £107.9m from £93.1m, primarily as a result of the increase in adjusted EBITDA.


1. Financial measures are defined in the 2023 Annual report